Solei Brand Launches New Cannabis Infused Cold Brew Teas
- None.
- None.
The introduction of two new cannabis-infused cold brew tea beverages by Tilray Brands, Inc. represents a strategic move to diversify its product offerings and cater to evolving consumer preferences in the cannabis and wellness market. The focus on non-carbonated, mildly sweet beverages with specific cannabinoid infusions suggests an attempt to target a niche segment that prefers subtle flavors and moderate psychoactive effects.
From a market perspective, the expansion into different beverage types, following the success of prior launches, indicates a pattern of innovation and responsiveness to market trends. The inclusion of CBG and CBD, alongside THC, aligns with the growing consumer interest in the entourage effect and the potential therapeutic benefits of a broader spectrum of cannabinoids.
Analyzing the potential market impact, the launch of these products could lead to increased shelf space in retail outlets and potentially higher sales volumes. However, it is important to monitor the consumer reception and sales data post-launch to assess the actual impact on Tilray's financial performance.
The release of new products by Tilray Brands, particularly in the cannabis-infused beverage sector, could have implications for the company's revenue streams and market share. The cannabis beverage market is still relatively nascent, with significant growth potential. As such, early movers like Tilray, who are expanding their product lines, could establish a strong foothold and benefit from first-mover advantages.
Investors should consider the costs associated with product development and marketing when evaluating the potential return on investment. It will be crucial to track the sales trajectory of these new offerings in subsequent financial reports to gauge their success and contribution to the company's overall financial health.
Furthermore, the regulatory environment remains a critical factor for the cannabis industry. Changes in legislation could either bolster the market for cannabis beverages or introduce new challenges, thus affecting investor sentiment and stock performance.
The launch of cannabis-infused beverages by Tilray Brands intersects with complex regulatory landscapes in Canada and potentially other markets. Compliance with Health Canada's regulations on cannabis products, including proper labeling, THC content limits and marketing restrictions, is essential for the successful distribution of these products.
Understanding the legal framework is vital for investors as non-compliance could lead to fines, product recalls, or other sanctions that negatively impact the company's reputation and financials. Moreover, international expansion plans for these products would require navigation through diverse legal systems, each with its own set of cannabis regulations, further complicating Tilray's business strategy.
REFRESHING ELEVATION IN EVERY SIP: Peach Cranberry and Wildberry Hibiscus Infused Cold Brew Teas are Now Available in Canada
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today debuts two new ready-to-drink cold brew tea beverages by its premium cannabis wellness brand, Solei. Introducing Peach Cranberry and Wildberry Hibiscus, Solei’s new cold brew tea offerings are non-carbonated and embrace a moderate elevation that’s mildly sweet and comes in 355ml per can.
Solei offers a range of versatile products and cannabinoid formulations for consumers to explore a handful of ways to enjoy products while socializing or unwinding. Leaning into cold brew teas, Solei continues to expand its beverage lineup following the success of its first-ever ready-to-drink infused beverage line featuring Mango Passionfruit and Dragonfruit Watermelon Sparkling CBD beverages, along with last year’s initial launch of its hot tea collection, including the beloved Lavender Chamomile CBN tea, and most recent fall tea editions with a spotlight on seasonal classics such as Chai Rooibos, with high CBN content.
Solei’s newly launched cold brew teas are produced with a black tea base and blended with real fruit juice to create a refreshing fizz-free experience. The two new refreshing flavours include:
- Peach Cranberry: Made with refreshing peach and cranberry juice blended with a black tea base and elevated with a 5mg THC and 10mg CBG infusion.
- Wildberry Hibiscus: Wildberry Hibiscus Cold Brew Teas are made with refreshing wild berries and hibiscus juice blended with a black tea base and elevated with a 5mg THC and 10mg CBD infusion.
Find out more about Solei’s Cold Brew Teas by visiting www.solei.ca and following our journey @soleicanada across socials. Sip Solei responsibly!
About Solei
Solei is a leading cannabis wellness and lifestyle brand with thoughtfully designed products for curating sensorial experiences based on what you need, when you need it, entirely on your terms. Beloved by consumers for its carefully formulated products and innovative formats, Solei products feature varied and rare cannabinoids that allow you to fine-tune your routines with ease. Explore a true sense of well-being with a wide range of formats including Solei’s best-selling CBD oils, ready-to-go pre-roll multi-packs, blended topicals, and new beverages, along with more exciting future launches coming later this year.
For more information on Solei, visit http://www.Solei.ca and follow along our journey @soleicanada on Instagram.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information on Tilray, visit Tilray Brands, Inc. and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
Contacts:
Media:
Kaitlin Macapagal
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
